News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
New Bristol-Myers Squibb Company, Pfizer Inc. Drug May Help Patients With Irregular Heartbeat Avoid Stroke
February 11, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(HealthDay News) -- A new anti-clotting drug works better than aspirin for stroke prevention in some patients with the common, sometimes lethal, heart rhythm problem known as atrial fibrillation, according to research presented Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 3
Pfizer
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Obesity
Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 data
July 23, 2026
·
3 min read
·
Tristan Manalac
Insights
Nordic biotech’s next act: From fragmentation to global force
July 23, 2026
·
1 min read
·
Jennifer C. Smith-Parker
SUPPORTED BY AMPLITY
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
July 22, 2026
·
1 min read
·
BioSpace Insights
Lung cancer
Summit and Akeso sharpen case for ivonescimab with new Western data
July 22, 2026
·
2 min read
·
Gabrielle Masson